NCT06049004Completed
Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
Investigation of the Validity and Reliability of the Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
Source: ClinicalTrials.gov · Last updated 5 Jun 2025
Brief summary (registry, in English)
The Londrina Activities of Daily Living Protocol was first developed for Chronic Obstructive Pulmonary Disease patients and was found to be valid and reliable, but there is no validity and reliability study of the Londrina Activities of Daily Living Protocol in IPF patients. The purpose of the study is to Examine the Validity and Reliability of the Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis (IPF) patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 15 Sept 2023
- Start date
- 1 Nov 2023
- Primary completion date
- 1 Jun 2024
- Lead sponsor
- Izmir Katip Celebi University
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT06049004
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 1 Nov 2023 to the primary completion date, 1 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- People with comorbidities that would make it impossible to perform any of the study evaluations (orthopedic pathology, uncontrolled cardiovascular or neurological conditions, psychiatric illness, etc.)
- Presence of infection in the last 3 months
Other
- The patient refuses to participate in the study
- Those who show changes in their usual symptoms during the protocol
- Patients who have difficulty understanding the commands given
- Those who cannot complete all evaluations
Who the study is looking for
- Being diagnosed with idiopathic pulmonary fibrosis (IPF) disease
- Being 18 years or older
- Being independent in daily living activities
- Being able to read and understand Turkish
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Izmir Katip Çelebi University Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.